Logo 871 (Glipizide extended release 2.5 mg)

Pill imprint Logo 871 has been identified as Glipizide extended release 2.5 mg.

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 2.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for Logo 871

Glipizide extended release 2.5 mg Logo 871  Front
Glipizide extended release 2.5 mg Logo 871  Back
Glipizide extended release
Imprint:
Logo 871
Strength:
2.5 mg
Color:
Blue
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Andrx Pharmaceuticals
National Drug Code (NDC):
62037-0871

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)